Malaria Vaccines Market Trends Supporting 34.3% CAGR Growth Through 2030

Malaria Vaccines Market Report

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Malaria Vaccines Market Size Forecast: How Big Could The Market Get By 2030?

The malaria vaccines market size has experienced substantial expansion in recent years. It is anticipated to increase from $6.24 billion in 2025 to $8.36 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 33.9%. This historical growth can be attributed to several factors: a high malaria burden in endemic areas, persistent global efforts to eradicate malaria, financial assistance from international health organizations, the constraints imposed by antimalarial drug resistance, and the initial successful outcomes of first-generation malaria vaccines.

The malaria vaccines market is anticipated to experience substantial expansion in the coming years. Its valuation is projected to reach $27.18 billion by 2030, growing at a compound annual growth rate (CAGR) of 34.3%. This projected growth can be attributed to factors such as increased government funding for the prevention of infectious diseases, the expanding geographical reach of malaria-prone areas due to climatic shifts, a rising need for vaccines offering sustained immunity, ongoing advancements in vaccine research and clinical trials, and the broadening of immunization programs in low-income countries. Significant trends for the forecast period include the development and deployment of next-generation malaria vaccines, an escalating focus on pediatric immunization initiatives, a surge in public–private collaborations for vaccine distribution, a heightened emphasis on multi-antigen and combination vaccines, and the reinforcement of extensive vaccination campaigns in regions where the disease is endemic.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=43664951&type=smp&name=Malaria%20Vaccines%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Malaria Vaccines Market Industry Drivers: What’s Behind The Revenue Growth?

The malaria vaccine market is anticipated to experience growth as a result of the rising prevalence of mosquito-related diseases, which are a diverse category of illnesses transmitted through the bite of an infected mosquito. The malaria vaccine, particularly the RTS, S/AS01 (RTS, S) vaccine, functions by training the immune system to identify and combat the parasite, thereby preventing and reducing the effects of these mosquito-borne infectious diseases. For illustration, in December 2024, the UK Health Security Agency (UKHSA), a UK-based government department, released its annual malaria report for 2023, indicating 2,106 reported cases of imported malaria in the UK. This figure represents a 26% increase compared to the cases documented in 2022. Therefore, the heightened incidence of mosquito-related diseases is a significant driver for the expansion of the malaria vaccine market.

Malaria Vaccines Market Segments: Where Is Growth Concentrated?

The malaria vaccines market covered in this report is segmented –

1) By Agent: Plasmodium Falciparum, Plasmodium Vivax

2) By Vaccine Type: Pre-Erythrocytic, Erythrocytic, Multi-antigen, Other Vaccines

3) By Route Of Administration: Intramuscular, Subcutaneous, Intradermal, Other Routes Of Administration

4) By Distribution Channel: Public, Private

Subsegments:

1) By Plasmodium Falciparum: RTS,S/AS01 Vaccine, Experimental Vaccines

2) By Plasmodium Vivax: Candidate Vaccines In Development, Combination Vaccines

#Malaria Vaccines Market Growth Trends: What’s Shaping The Future Outlook?

Leading entities within the malaria vaccines market are prioritizing the creation of innovative solutions, such as next-generation recombinant vaccines, to address the escalating need fueled by increasing malaria prevalence, government support, and expanding immunization programs. These advanced recombinant vaccines employ sophisticated genetic engineering methodologies to aim at various phases of the malaria parasite’s life cycle, delivering enhanced immunological reactions and extended defense, in contrast to conventional vaccines, which typically focus on a singular stage and provide restricted effectiveness. As an illustration, during October 2025, the Government of the Republic of Zambia introduced the anti-malarial vaccine R21/Matrix-M under the umbrella of its Expanded Programme on Immunisation. A collaborative effort between the University of Oxford and the Serum Institute of India, this vaccine utilizes a recombinant protein framework coupled with the Matrix-M adjuvant to boost immunological response, follows a four-dose regimen beginning at 6 months of age, and is intended to supplement current anti-malaria interventions. The vaccine demonstrates superior efficacy rates and is designed to safeguard children within high and moderate transmission districts across Zambia, thereby making a substantial contribution to endeavors aimed at eradicating malaria.

Malaria Vaccines Market Key Participants And Competitive Landscape

Major companies operating in the malaria vaccines market are GlaxoSmithKline Plc, Bharat Biotech International Limited, Serum Institute of India Private Limited, Sanaria Inc, BioNTech SE, Moderna Inc, Pfizer Inc, Novavax Inc, Takeda Pharmaceutical Company Limited, Sanofi SA, Zydus Lifesciences Limited, Valneva SE, GeoVax Labs Inc, Inovio Pharmaceuticals Inc, Vaxart Inc, CanSino Biologics Inc, Sinovac Biotech Ltd, Clover Biopharmaceuticals Inc, Biological E Limited, Emergent BioSolutions Inc

View The Full Malaria Vaccines Market Report:

https://thebusinessresearchcompany.com/report/malaria-vaccines-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Malaria Vaccines Market Top Region: Where Does Most Revenue Come From?

North America was the largest region in the malaria vaccines market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the malaria vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model